[1]贾洋洋,王吉利,李小玉,等.毛蕊异黄酮治疗骨和软骨代谢相关疾病作用机制的研究进展[J].中医正骨,2025,37(08):30-35.
点击复制

毛蕊异黄酮治疗骨和软骨代谢相关疾病作用机制的研究进展()

《中医正骨》[ISSN:1001-6015/CN:41-1162/R]

卷:
第37卷
期数:
2025年08期
页码:
30-35
栏目:
综述
出版日期:
2025-08-20

文章信息/Info

作者:
贾洋洋1王吉利2李小玉2陈飞飞3王若秦1郭少冲4刘昕岩4郑永智2
1.河南中医药大学第二临床医学院,河南 郑州 450002; 2.河南省中医院,河南 郑州 450002; 3.河南省胸科医院,河南 郑州 450008; 4.河南中医药大学骨伤学院,河南 郑州 450002
关键词:
骨质疏松 骨关节炎 关节炎类风湿 毛蕊异黄酮 综述
摘要:
毛蕊异黄酮是从中药黄芪中提取的一种异黄酮类化合物,具有抗骨质疏松、抗炎、抗氧化等多种药理活性。骨质疏松症、骨关节炎、类风湿关节炎等疾病以骨和软骨破坏为主要病理特征,其发生发展与骨和软骨代谢异常、炎症反应及氧化应激等关系密切。毛蕊异黄酮可能通过促进成骨细胞分化、抑制破骨细胞活性治疗骨质疏松症,通过抑制炎症反应和软骨细胞凋亡、维持软骨细胞和细胞外基质的代谢平衡治疗骨关节炎,通过抗氧化应激和调节促炎性细胞因子水平治疗类风湿关节炎。本文对毛蕊异黄酮治疗骨与软骨代谢相关疾病作用机制的研究进展进行了综述,为此类药物的开发和临床应用提供了参考。

参考文献/References:

[1] WANG Y L,LIANG Y Z,ZHANG J,et al.Simultaneous separation and determination of four main isoflavonoids in Astragali Radix by an isocratic LC/ESI-MS method[J].J Cent South Univ,2016,23(2):303-309.
[2] TOUKAM P D,TAGATSING M F,YAMTHE L R T,et al.Novel saponin and benzofuran isoflavonoid with in vitro anti-inflammatory and free radical scavenging activities from the stem bark of Pterocarpus erinaceus(Poir)[J].Phytochemistry Letters,2018,28:69-75.
[3] SEONG S H,ROY A,JUNG H A,et al.Protein tyrosine phosphatase 1B and α-glucosidase inhibitory activities of pueraria lobata root and its constituents[J].J Ethnopharmaco,2016,194:706-716.
[4] HUANG Q,XU L,QU W S,et al.TLC bioautography-guided isolation of antioxidant activity components of extracts from Sophora flavescens ait[J].Eur Food Res Technol,2017,243(7):1127-1136.
[5] LIN L Z, HE X G, LINDENMAIER M, et al.Liquid chromatography-electrospray ionization mass spectrometry study of the flavonoids of the roots of Astragalus mongholicus and A.membranaceus[J].J Chromatogr A,2000,876(1-2):87-95.
[6] SOHEL M,ZAHRA SHOVA F T,SHUVO S,et al.Unvei-ling the potential anti-cancer activity of calycosin against multivarious cancers with molecular insights:a promising frontier in cancer research[J].Cancer Med,2024,13(3):e6924.
[7] DENG M,CHEN H,LONG J,et al.Calycosin:a review of its pharmacological effects and application prospects[J].Expert Rev Anti Infect Ther,2021,19(7):911-925.
[8] 史东梅,董明,陆颖,等.PI3K/PKB信号通路与骨破坏:问题与机制[J].中国组织工程研究,2020,24(23):3716-3722.
[9] VARGAS-FRANCO J W,CASTANEDA B,RÉDINÍ F,et al.Paradoxical side effects of bisphosphonates on the skeleton:what do we know and what can we do?[J].Cell Physiol,2018,233(8):5696-5715.
[10] WALKER M D,SHANE E.Postmenopausal osteoporo-sis[J].N Engl J Med,2023,389(21):1979-1991.
[11] BLACK D M,SCHWARTZ A V,ENSRUD K E,et al.Effects of continuing or stopping alendronate after 5 years of treatment:the fracture intervention trial long-term extension(FLEX):a randomized trial[J].JAMA,2006,296(24):2927-2938.
[12] ZENG C,WEI J,PERSSON M S M,et al.Relative efficacy and safety of topical non-steroidal anti-inflammatory drugs for osteoarthritis:a systematic review and network meta-analysis of randomised controlled trials and observational studies[J].Br J Sports Med,2018,52(10):642-650.
[13] SERHAL L,LWIN M N,HOLROYD C,et al.Rheumatoid arthritis in the elderly:characteristics and treatment consi-derations[J].Autoimmun Rev,2020,19(6):102528.
[14] RUAN J Q,YAN R.Regioselective glucuronidation of the isoflavone calycosin by human liver microsomes and recombinant human UDP-glucuronosyltransferases[J].Chem Biol Interact,2014,220:231-240.
[15] WANG Y,WANG P, XIE J,et al.Pharmacokinetic com-parisons of different combinations of yigan jiangzhi formula in rats:simultaneous determination of fourteen components by UPLC-MS/MS[J].J Anal Methods Chem,2020,2020:9353975.
[16] ZHAO H,ZHANG Y,GUO Y,et al.Identification of major α-glucosidase inhibitors in Radix Astragali and its human microsomal metabolites using ultrafiltration HPLC-DAD-MS(n.)[J].J Pharm Biomed Anal,2015,104:31-37.
[17] LIANG B,BURLEY G,LIN S,et al.Osteoporosis pathogenesis and treatment:existing and emerging avenues[J].Cell Mol Biol Lett,2022,27(1):72.
[18] GONG Y,YANG J,LI X,et al.Asystematic dissection of human primary osteoblasts in vivo at single-cell resolution[J].Aging(Albany NY),2021,13(16):20629-20650.
[19] KONG X,WANG F,NIU Y,et al.A comparative study on the effect of promoting the osteogenic function of osteoblasts using isoflavones from Radix Astragalus[J].Phytother Res,2018,32(1):115-124.
[20] FANG Y,XUE Z,ZHAO L,et al.Calycosin stimulates the osteogenic differentiation of rat calvarial osteoblasts by activating the IGF1R/PI3K/PKB signaling pathway[J].Cell Biol Int,2019,43(3):323-332.
[21] GONG A G W,DUAN R,WANG H Y,et al.Calycosin orchestrates osteogenesis of danggui buxue tang in cultured osteoblasts:evaluating the mechanism of action by omics and chemical knock-out methodologies[J].Front Pharmacol,2018,9:36.
[22] JIANG H,WANG Y,TANG Z,et al.Calycosin alleviates titanium particle-induced osteolysis by modulating macrophage polarization and subsequent osteogenic differentiation[J].J Cell Mol Med,2024,28(7):e18157.
[23] ZHOU H,LEE J.Nanoscale hydroxyapatite particles for bone tissue engineering [J].Acta Biomater,2011,7(7):2769-2781.
[24] 智信,陈晓,苏佳灿.绝经后骨质疏松症发病机制研究进展[J].中国骨质疏松杂志,2018,24(11):1510-1513.
[25] ARAI M,SHIBATA Y,PUGDEE K,et al.Effects of reactive oxygen species(ROS)on antioxidant system and osteoblastic differentiation in MC3T3-E1 cells[J].IUBMB Life,2007,59(1):27-33.
[26] IBÁÑEZ L,FERRÁNDIZ M L,BRINES R,et al.Effects of Nrf2 deficiency on bone microarchitecture in an experimental model of osteoporosis[J].Oxid Med Cell Longev,2014,2014:726590.
[27] ZHANG Y,YANG J H.Activation of the PI3K/PKB pathway by oxidative stress mediates high glucose-induced increase of adipogenic differentiation in primary rat osteoblasts[J].J Cell Biochem,2013,114(11):2595-2602.
[28] FU L F,WU W L,ZHU J,et al.Calycosin regulates glucocorticoid-induced apoptosis via Nrf2/ARE signaling in MC3T3-E1 cells[J].Trop J Pharm Res,2018,17(2):205-212.
[29] VON KAEPPLER E P,WANG Q,RAGHU H,et al.Interleukin 4 promotes anti- inflammatory macrophages that clear cartilage debris and inhibits osteoclast development to protect against osteoarthritis[J].Clin Immunol,2021,229:108784.
[30] DANKS L,TAKAYANAGI H.Immunology and bone[J].J Biochem,2013,154(1):29-39.
[31] ONO T,NAKASHIMA T.Recent advances in osteoclast biology[J].Histochem Cell Biol,2018,149(4):325-341.
[32] LI Y,ZHUANG Q,TAO L,et al.Urolithin B suppressed osteoclast activation and reduced bone loss of osteoporosis via inhibiting ERK/NF-κB pathway[J].Cell Prolif,2022,55(10):e13291.
[33] QUAN G H,WANG H,CAO J,et al.Calycosin suppresses RANKL-mediated osteoclastogenesis through inhibition of MAPKs and NF-κB[J].Int J Mol Sci,2015,16(12):29496-29507.
[34] 徐鹏,邹任玲,张冬青.糖蛋白130相关炎症因子介导RA患者破骨细胞分化的初步研究[J].中国免疫学杂志,2020,36(4):467-471.
[35] PIBER D,OLMSTEAD R,CHO J H,et al.Disturbance of sleep maintenance,but not sleep duration,activates nuclear factor-κB and signal transducer and activator of transcription family proteins in older adults:sex differences[J].Sleep,2023,46(10):zsad130.
[36] DA COSTA R M,NEVES K B,MESTRINER F L,et al.TNF-α induces vascular insulin resistance via positive modulation of PTEN and decreased PKB/eNOS/NO signaling in high fat diet-fed mice[J].Cardiovasc Diabetol,2016,15(1):119.
[37] DONG L,YIN L,CHEN R,et al.Anti-inflammatory effect of Calycosin glycoside on lipopolysaccharide-induced inflammatory responses in RAW 264.7 cells[J].Gene,2018,675:94-101.
[38] JIN X,WANG H,LIANG X,et al.Calycosin prevents bone loss induced by hindlimb unloading[J].NPJ Microgravity,2022,8(1):23.
[39] LI N,TU Y,SHEN Y,et al.Calycosin attenuates osteoporosis and regulates the expression of OPG/RANKL in ovariectomized rats via MAPK signaling[J].Pharmazie,2016,71(10):607-612.
[40] MARTEL-PELLETIER J,BARR A J,CICUTTINI F M,et al.Osteoarthritis[J].Nat Rev Dis Primers,2016,2:16072.
[41] MALEMUD C J.Biologic basis of osteoarthritis:state of the evidence[J].Curr Opin Rheumatol,2015,27(3):289-294.
[42] RIGOGLOU S,PAPAVASSILIOU A G.The NF-κB signalling pathway in osteoarthritis[J].Int J Biochem Cell Biol,2013,45(11):2580-2584.
[43] GUAN T,DING L G,LU B Y,et al.Combined administration of curcumin and chondroitin sulfate alleviates cartilage injury and inflammation via NF-κB pathway in knee osteoarthritis rats[J].Front Pharmacol,2022,13:882304.
[44] YU H,LIN L,ZHANG Z,et al.Targeting NF-κB pathway for the therapy of diseases:mechanism and clinical study[J].Signal Transduct Target Ther,2020,5(1):209.
[45] WOJDASIEWICZ P,PONIATOWSKI  A,SZUKIEWICZ D.The role of inflammatory and anti-inflammatory cytokines in the pathogenesis of osteoarthritis[J].Mediators Inflamm,2014,2014:561459.
[46] XU K,HE Y,MOQBEL S A A,et al.SIRT3 ameliorates osteoarthritis via regulating chondrocyte autophagy and apoptosis through the PI3K/PKB/mTOR pathway[J].Int J Biol Macromol,2021,175:351-360.
[47] SUN K,LUO J,GUO J,et al.The PI3K/PKB/mTOR signaling pathway in osteoarthritis:a narrative review[J].Osteoarthritis Cartilage,2020,28(4):400-409.
[48] SHI X,JIE L,WU P,et al.Calycosin mitigates chondrocyte inflammation and apoptosis by inhibiting the PI3K/PKB and NF-κB pathways[J].J Ethnopharmacol,2022,297:115536.
[49] GUO X,PAN X,WU J,et al.Calycosin prevents IL-1β-induced articular chondrocyte damage in osteoarthritis through regulating the PI3K/PKB/FoxO1 pathway[J].In Vitro Cell Dev Biol Anim,2022,58(6):491-502.
[50] 牛鲁豫,张涛,李嘉萌,等.软骨稳态与骨关节炎关系的研究进展[J].中华骨与关节外科杂志,2024,17(4):377-384.
[51] PENG Z,SUN H,BUNPETCH V,et al.The regulation of cartilage extracellular matrix homeostasis in joint cartilage degeneration and regeneration[J].Biomaterials,2021,268:120555.
[52] PEARLE A D,WARREN R F,RODEO S A.Basic science of articular cartilage and osteoarthritis[J].Clin Sports Med,2005,24(1):1-12.
[53] SU H,YAN Q,DU W,et al.Calycosin ameliorates osteoarthritis by regulating the imbalance between chondrocyte synthesis and catabolism[J].BMC Complement Med Ther,2024,24(1):48.
[54] RATERMAN H G,LEMS W F.Pharmacological management of osteoporosis in rheumatoid arthritis patients:a review of the literature and practical guide[J].Drugs Aging,2019,36(12):1061-1072.
[55] 范铭婕,林龙飞,汤如莹,等.中药黄酮类化合物治疗类风湿性关节炎的研究进展[J].中国实验方剂学杂志,2025,31(17):244-251.
[56] KARDES S,KARAGÜLLE M,DURAK I,et al.Association of oxidative stress with clinical characteristics in patients with rheumatoid arthritis[J].Eur J Clin Invest,2018,48(1):12858.
[57] QUIÑONEZ-FLORES C M,GONZÁLEZ-CHÁVEZ S A,DEL RÍO NÁJERA D,et al.Oxidative stress relevance in the pathogenesis of the rheumatoid arthritis:a systematic review[J].Biomed Res Int,2016,2016:6097417.
[58] LIU S,PI J,ZHANG Q.Signal amplification in the KEAP1-NRF2-ARE antioxidant response pathway[J].Redox Biol,2022,54:102389.
[59] SUN H,LU S,QU G,et al.Mesenchymal stem cells-derived exosomes ameliorate high glucose and lipopolysaccharide-induced HPMECs injury through the Nrf2/HO-1 pathway[J].Autoimmunity,2023,56(1):2290357.
[60] HE F,RU X,WEN T.NRF2,a transcription factor for stress response and beyond[J].Int J Mol Sci,2020,21(13):4777.
[61] APARICIO R,HANSEN M,WALKER D W,et al.The selective autophagy receptor SQSTM1/p62 improves lifespan and proteostasis in an evolutionarily conserved manner[J].Autophagy,2020,16(4):772-774.
[62] SU X,HUANG Q,CHEN J,et al.Calycosin suppresses expression of pro-inflammatory cytokines via the activation of p62/Nrf2-linked heme oxygenase 1 in rheumatoid arthritis synovial fibroblasts[J].Pharmacol Res,2016,113(PtA):695-704.
[63] KOMATSU N,TAKAYANAGI H.Mechanisms of joint destruction in rheumatoid arthritis-immune cell-fibroblast-bone interactions[J].Nat Rev Rheumatol,2022,18(7):415-429.
[64] WANG F,LIU J.The dual anti-inflammatory and anticoagulant effects of Jianpi Huashi Tongluo prescription on rheumatoid arthritis through inhibiting the activation of the PI3K/PKB signaling pathway[J].Front Pharmacol,2025,16:1541314.
[65] ZHU L,HUA F,DING W,et al.The correlation between the Th17/Treg cell balance and bone health[J].Immun Ageing,2020,17:30.
[66] HUANG F,WONG P, LI J, et al.Osteoimmunology:the correlation between osteoclasts and the Th17/Treg balance in osteoporosis[J].J Cell Mol Med,2022,26(13):3591-3597.

相似文献/References:

[1]樊庆阳,任凯晶.定制3D打印切模辅助全膝关节置换术治疗 膝骨关节炎合并股骨干骨折畸形愈合[J].中医正骨,2015,27(11):37.
[2]李林军.应用膨胀式椎弓根螺钉内固定治疗合并骨质疏松的 胸腰椎退行性疾病[J].中医正骨,2015,27(08):49.
[3]应俊,张元斌,罗程,等.核转录因子-κB在骨关节炎炎症反应中的作用[J].中医正骨,2015,27(07):40.
[4]韩艳,温利平,刘娜,等.补肾活血方对去卵巢大鼠骨代谢及骨密度的影响[J].中医正骨,2015,27(12):7.
 HAN Yan,WEN Liping,LIU Na,et al.Effect of Bushen Huoxue Fang(补肾活血方)on bone metabolism and bone mineral density in the ovariectomized rats[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(08):7.
[5]李学朋,朱立国.骨疏康胶囊对去卵巢大鼠骨小梁的影响[J].中医正骨,2015,27(12):12.
 LI Xuepeng,ZHU Liguo.Effect of Gushukang Jiaonang(骨疏康胶囊)on bone trabecula in the ovariectomized rats[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(08):12.
[6]冯荣,王平,李炳奇,等.铍针刺络拔罐结合中药口服治疗膝骨关节炎合并 原发性血小板增多症1例[J].中医正骨,2015,27(12):73.
[7]高宁阳,丁立,庞坚,等.miRNAs与骨关节炎关系的研究进展[J].中医正骨,2015,27(12):74.
[8]陈冠军,陈扬,庄汝杰.可灌注骨水泥椎弓根螺钉系统 在老年腰椎疾患手术中的应用[J].中医正骨,2015,27(02):40.
[9]蔡云仙.围手术期耳穴按压联合平衡针疗法 在全膝关节置换术后镇痛中的应用[J].中医正骨,2015,27(06):41.
[10]魏瑄,宋树春,王金良.术前精确测量和评估在全髋关节置换治疗 成人发育性髋关节发育不良继发骨关节炎中的价值[J].中医正骨,2015,27(01):30.
[11]潘毅博,李勇,覃肯,等.绝经后骨质疏松症与膝骨关节炎共病的机制及补肾调髓类中药干预机制的研究进展[J].中医正骨,2025,37(08):24.

备注/Memo

备注/Memo:
基金项目:河南省科技发展计划项目(242102310522,242102310539); 河南省高等学校重点科研项目(23A360023,25B360014); 河南省医学科技攻关计划联合共建项目(LHGJ20240660); 河南省卫生健康委员会国家中医药传承创新中心联合共建科研专项项目(2024ZXZX1196)
通讯作者:郑永智 E-mail:zyz15838066078@126.com
更新日期/Last Update: 1900-01-01